The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of the
Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer
β Scribed by Andrew M. Hanby; David P. Kelsell; Henry W. Potts; Cheryl E. Gillett; D. Timothy Bishop; Nigel K. Spurr; Diana M. Barnes
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 61 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Approximately 2% to 5% of all breast cancers are hereditary, meaning that the cancer predisposition is carried as a monogenic trait. Several highly penetrant breast cancer predisposing genes have been identified. These discoveries will permit a refined description of breast cancer occurring as part
Several lines of evidence suggest a relationship between the occurrence of meningiomas and that of breast carcinomas: Both occur more frequently in women than in men, and a higher incidence of meningiomas has been observed in patients with a history of breast carcinoma. Both tumor types also express